Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- RIVANNA MEDICAL, INC.
- Proposal award date
- 2013-09-15
- Contract end date
- 2015-08-31
- UEI
- S1DYEWHL6PC3
- Solicitation number
- Not reported
- Topic code
- EI
Research abstract
This Small Business Innovation Research (SBIR) Phase II project addresses the clinical and market need for an X-ray replacement technology that is portable, low-cost, and safe. While X-ray is the current dominant modality for diagnostic imaging of bone anatomy, it possesses many limitations: emission of radiation, bulky, and expensive. In the Phase I project, we demonstrated feasibility of the technology with a handheld ultrasound prototype, which demonstrated 3D freehand bone imaging using an ex vivo whole pig lumbar spine model. Phase II research objectives include: 1) Design and build a preproduction ultrasound prototype; 2) Develop a model registration-based 3D bone imaging application and release a clinical software version with formal verification and validation testing; and 3) Prepare the device for clinical use with human subjects and experimentally validate in an ex vivo porcine lumbar spine model with physician testing. It is anticipated that this project will result in the demonstration of a new medical device with demonstrated efficacy for improved administration of spinal anesthesia via 3D portable real-time spinal bone imaging. The broader impact/commercial potential of this project is an X-ray replacement technology based on medical ultrasound, which addresses market segments including spinal anesthesia, orthopedic, and emergency medicine. Rivanna Medical is targeting the spinal anesthesia market first because of the compelling market and clinical need. Due to lack of availability of safe, portable, and inexpensive medical imaging for bone anatomy, these procedures currently exhibit high first-attempt failure rates. Failures result in poor patient outcomes and higher costs for health care providers. In this application, our lead device, the SpineFinder, would improve success rates via real-time guidance of spinal injections at the patient?s bedside. The societal impact of a safe, inexpensive, portable bone imaging products includes more successful procedures, better patient outcomes, and lower healthcare costs. Additionally, the public would benefit by an overall reduction in ionizing radiation exposure from X-ray and a subsequent reduction in cancers. The general scientific and technological understanding of acoustics will be enhanced through this project by a better understanding of ultrasound interactions with specular reflecting surfaces, such as bone.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
13 SBIR/STTR records share this UEI (2012–2025). Reported award amounts total $15,426,220. Reported amounts are not federal obligations.
Phases: Phase II, Phase II – Direct to Phase II, Phase I
Agencies: Department of Health and Human Services, National Science Foundation
Contractor profile
RIVANNA MEDICAL, INC.
Historical federal award activity, when published, is on that contractor profile. Matched by UEI only.
Agency intelligence
National Science Foundation
NAICS intelligence
This classification comes from the contractor profile, not from the SBIR award record.
Contractor industry classification NAICS 541512
Back to SBIR/STTR Research Awards